HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard L Wasserman Selected Research

Primary Immunodeficiency Diseases

1/2022Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases.
1/2019Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.
12/2017RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
10/2017Gammaplex® 5 and 10% in the treatment of primary immunodeficiency and chronic immune thrombocytopenic purpura.
4/2017Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
2/2017Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes.
2/2017Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.
1/2017Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases.
11/2016The Nuts and Bolts of Immunoglobulin Treatment for Antibody Deficiency.
1/2016Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard L Wasserman Research Topics

Disease

18Primary Immunodeficiency Diseases
01/2022 - 07/2006
12Infections
01/2022 - 09/2010
6Food Hypersensitivity (Food Allergy)
11/2021 - 01/2011
6Hypersensitivity (Allergy)
11/2020 - 04/2006
6Hereditary Angioedemas
09/2012 - 10/2009
4Asthma (Bronchial Asthma)
05/2010 - 04/2006
2Bacterial Infections (Bacterial Infection)
01/2021 - 01/2016
2Body Weight (Weight, Body)
01/2021 - 10/2009
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2017 - 04/2017
2Edema (Dropsy)
11/2010 - 08/2010
2Common Variable Immunodeficiency
06/2009 - 01/2009
1Hemorrhage
10/2017
1Measles
01/2016
1Poliomyelitis (Polio)
01/2016
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
08/2014
1Lymphopenia (Lymphocytopenia)
08/2014
1Peanut Hypersensitivity (Peanut Allergy)
01/2014
1DiGeorge Syndrome (Syndrome, DiGeorge)
02/2012
1Vomiting
10/2009
1Angioedema
10/2009
1Bruton type agammaglobulinemia
01/2009
1Fatigue
02/2008
1Headache (Headaches)
02/2008
1Chronic Obstructive Pulmonary Disease (COPD)
11/2006

Drug/Important Bio-Agent (IBA)

13Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 04/2006
11Immunoglobulins (Immunoglobulin)IBA
01/2022 - 02/2008
10Immunoglobulin G (IgG)IBA
10/2017 - 09/2010
5Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
07/2012 - 10/2009
3AllergensIBA
01/2021 - 07/2014
3Proline (L-Proline)FDA Link
02/2012 - 01/2009
2Anti-Bacterial Agents (Antibiotics)IBA
11/2018 - 08/2014
2Neutralizing AntibodiesIBA
12/2017 - 01/2016
2Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2017 - 01/2016
2AntibodiesIBA
01/2016 - 06/2011
2Immunoglobulin E (IgE)IBA
08/2015 - 07/2014
2HizentraIBA
02/2014 - 09/2010
2Albuterol (Salbutamol)FDA LinkGeneric
11/2006 - 06/2006
1Therapeutic UsesIBA
04/2017
1ElementsIBA
11/2016
1VaccinesIBA
08/2014
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2014
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2014
1antineoplaston A10 (A 10)IBA
06/2011
1apaflurane (hydrofluoroalkane)IBA
11/2006
1Fluticasone (Cutivate)FDA LinkGeneric
06/2006
1GlucocorticoidsIBA
06/2006
1Hydrocortisone (Cortisol)FDA LinkGeneric
06/2006

Therapy/Procedure

14Therapeutics
01/2021 - 06/2006
7Immunotherapy
11/2021 - 01/2011
1Emergency Treatment
11/2010
1Aftercare (After-Treatment)
10/2009
1Subcutaneous Infusions
02/2008
1Metered Dose Inhalers (Metered Dose Inhaler)
06/2006